Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancer
Abstract. Background:. The purpose of this report is to summarize the evidence supporting supplementation of n-3 polyunsaturated fatty acids (n-3 PUFAs) in adult cancer patients, and to offer a better understanding of the appropriate use of n-3 PUFAs in the clinical setting. Methods:. Numerous data...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health - Lippincott Williams Wilkins
2025-03-01
|
| Series: | Journal of Nutritional Oncology |
| Online Access: | http://journals.lww.com/10.1097/JN9.0000000000000046 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850039332379820032 |
|---|---|
| author | Jing-Shu Yang Hai-Yan Wang Xin-Ting Zhang Song-Yu Wang Xiao-Tian Duan Quan-Tong Zhao Ran Wang Yao Wang Hong-Shi Cao |
| author_facet | Jing-Shu Yang Hai-Yan Wang Xin-Ting Zhang Song-Yu Wang Xiao-Tian Duan Quan-Tong Zhao Ran Wang Yao Wang Hong-Shi Cao |
| author_sort | Jing-Shu Yang |
| collection | DOAJ |
| description | Abstract.
Background:. The purpose of this report is to summarize the evidence supporting supplementation of n-3 polyunsaturated fatty acids (n-3 PUFAs) in adult cancer patients, and to offer a better understanding of the appropriate use of n-3 PUFAs in the clinical setting.
Methods:. Numerous databases were searched for guidelines, clinical decision-making documents, systematic reviews, expert consensus statements, and best evidence summaries about the use of n-3 PUFAs in cancer patients from the inception of the database to December 31, 2023. Evidence grading and recommendation rating were conducted. The data extracted included the timing of supplementation, symptom management, disease prevention, cost-effectiveness, route of administration, application scenarios, dosage, and safety.
Results:. The collected data show that n-3 PUFAs are safe for patients receiving chemotherapy who are at risk of malnutrition and cachexia. Moreover, n-3 PUFA supplementation can alleviate the adverse symptoms associated with chemotherapy, extend survival, and improve the quality of life of patients with cancer.
Conclusions:. The administration of supplementary n-3 PUFAs should be considered based on the patient’s disease stage, treatment plan, nutritional status, and tolerance, as well as the dosage, route and application scenarios. Promoting the clinical use of n-3 PUFAs may improve the outcomes for patients with cancer. |
| format | Article |
| id | doaj-art-8cd22fa3f15f45fe810d1e1bf952e976 |
| institution | DOAJ |
| issn | 2096-2746 2834-5371 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Wolters Kluwer Health - Lippincott Williams Wilkins |
| record_format | Article |
| series | Journal of Nutritional Oncology |
| spelling | doaj-art-8cd22fa3f15f45fe810d1e1bf952e9762025-08-20T02:56:23ZengWolters Kluwer Health - Lippincott Williams WilkinsJournal of Nutritional Oncology2096-27462834-53712025-03-011011710.1097/JN9.0000000000000046202503000-00001Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancerJing-Shu Yang0Hai-Yan Wang1Xin-Ting Zhang2Song-Yu Wang3Xiao-Tian Duan4Quan-Tong Zhao5Ran Wang6Yao Wang7Hong-Shi Cao8 1 Department of Oncology, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, China 2 Department of Nursing, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, China 3 Department of Neurotrauma Surgery, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, China 2 Department of Nursing, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, China 2 Department of Nursing, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, China 2 Department of Nursing, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, China 2 Department of Nursing, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, China 2 Department of Nursing, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, China 2 Department of Nursing, The First Bethune Hospital of Jilin University, Changchun 130021, Jilin, ChinaAbstract. Background:. The purpose of this report is to summarize the evidence supporting supplementation of n-3 polyunsaturated fatty acids (n-3 PUFAs) in adult cancer patients, and to offer a better understanding of the appropriate use of n-3 PUFAs in the clinical setting. Methods:. Numerous databases were searched for guidelines, clinical decision-making documents, systematic reviews, expert consensus statements, and best evidence summaries about the use of n-3 PUFAs in cancer patients from the inception of the database to December 31, 2023. Evidence grading and recommendation rating were conducted. The data extracted included the timing of supplementation, symptom management, disease prevention, cost-effectiveness, route of administration, application scenarios, dosage, and safety. Results:. The collected data show that n-3 PUFAs are safe for patients receiving chemotherapy who are at risk of malnutrition and cachexia. Moreover, n-3 PUFA supplementation can alleviate the adverse symptoms associated with chemotherapy, extend survival, and improve the quality of life of patients with cancer. Conclusions:. The administration of supplementary n-3 PUFAs should be considered based on the patient’s disease stage, treatment plan, nutritional status, and tolerance, as well as the dosage, route and application scenarios. Promoting the clinical use of n-3 PUFAs may improve the outcomes for patients with cancer.http://journals.lww.com/10.1097/JN9.0000000000000046 |
| spellingShingle | Jing-Shu Yang Hai-Yan Wang Xin-Ting Zhang Song-Yu Wang Xiao-Tian Duan Quan-Tong Zhao Ran Wang Yao Wang Hong-Shi Cao Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancer Journal of Nutritional Oncology |
| title | Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancer |
| title_full | Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancer |
| title_fullStr | Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancer |
| title_full_unstemmed | Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancer |
| title_short | Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancer |
| title_sort | supplemental n 3 polyunsaturated fatty acids clinical implications and best practices for adult patients with cancer |
| url | http://journals.lww.com/10.1097/JN9.0000000000000046 |
| work_keys_str_mv | AT jingshuyang supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer AT haiyanwang supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer AT xintingzhang supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer AT songyuwang supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer AT xiaotianduan supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer AT quantongzhao supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer AT ranwang supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer AT yaowang supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer AT hongshicao supplementaln3polyunsaturatedfattyacidsclinicalimplicationsandbestpracticesforadultpatientswithcancer |